期刊文献+

脱氢表雄酮在妇产科领域的应用研究 被引量:5

Application of DHEA in Obstetrics and Gynecology
下载PDF
导出
摘要 脱氢表雄酮(DHEA)及其硫酸盐硫酸脱氢表雄酮(DHEAS)是人体内最丰富的甾体物质,其生理作用机制尚不清楚。低水平的DHEA不仅与年龄有关,而且与糖尿病、心血管疾病、神经及免疫疾病有关。DHEA的临床应用研究已成为热点,尤其是在女性中的应用,其临床有效性在国外受到公认,但仍然缺少大量的证据支持DHEA应用的安全性。DHEA在女性中的临床研究需要大量设计科学严谨的随机对照试验。综述DHEA在妇产科的应用。 The mechanism of action of dehydroepiandrosterone (DHEA) and its sulphate DHEAS, the most abundant sex steroids in human, are not well understood. Low levels of DHEA are associated not only with the ageing process but also with diabetes mellitus,cardiovascular diseases and some neurological or immunological diseases. Clinical application and practice of DHEA have been a topic ,especially in women. Although its effectiveness has been universally acknowledged,there is scant evidence to support the safety of DHEA in clinical therapy. It is necessary to conduct the adequately powered,well-designed and randomized, and placebo-controlled trials to evaluate the clinical application of DHEA.
作者 张阳阳 徐阳
出处 《国际生殖健康/计划生育杂志》 CAS 2012年第4期291-294,311,共5页 Journal of International Reproductive Health/Family Planning
关键词 硫酸脱氢表雄酮 卵巢功能早衰 受精 体外 流产 围绝经期 Dehydroepiandrosterone sulfate Ovarian failure,premature Fertilization in vitro Abortion Perimenopause
  • 相关文献

参考文献30

  • 1Giordano R,Di Vito L,Lanfranco F,et al. Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH (1-24) [J]. Clin Endocrinol (Oxf) , 2001,55(2) :259-265.
  • 2Labrie F. DHEA after Menopause-Sole source of sex steroids and potential sex steroid deficiency treatment [J].Menopause, 2010, 19: 14-24.
  • 3Bedaiwy MA, Ryan E, Shaaban O, et al. Follicular conditioning with dehydroepiandrosterone pre-treatment improves the outcome of intrauterine insemination clomiphene citrate resistant patients [J]. Fertil Steril , 2009 , 93 (Suppl 10): 239.
  • 4Gleicher N, Weghofer A,Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation [J]. Reprod Biomed Online,2010,21(3):360-365.
  • 5Brill H,Barad DH,Gleicher N. Dehydroepiandrosterone(DHEA) supplementation and pregnancy outcome: Effect on pregnancy rate and speed of conception [J]. Fertil Steril,2006,86(Suppl 3): 124-125.
  • 6Wiser A, Gonen O, Ghetler Y ,et al. Addition of dehydroepiandrosterone (DHEA)for poor -responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study [J]. Hum Reprod,2010,25(10) :2496-2500.
  • 7Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)[J]. Reprod Biol Endocrinol,2011 ,9:67.
  • 8Mamas L,Mamas E. Premature ovarian failure and dehydroepiandrosterone [J]. Fertil Steril ,2009, 91(2): 644-646.
  • 9Gleicher N, Ryan E, Weghofer A, et al. Miscarriage rates after dehydroepiandrosterone (DHEA)supplementation in women with diminished ovarian reserve: a case control study [J]. Reprod Biol Endocrinol , 2009,7: 108.
  • 10Beral V, Reeves G, Bull D, et al. Breast cancer risk in relation to the interval between menopause and starting hormone therapy [J]. J Natl Cancer Inst , 2011 ,103(4):296-305.

同被引文献56

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部